Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant.
Garcia-Rosa M, Abraham A, Bertaina A, Bhoopalan SV, Bonfim C, Cohen S, DeZern A, Louis C, Oved J, Pavel-Dinu M, Purtill D, Ruggeri A, Russell A, Sharma A, Wynn R, Boelens JJ, Prockop S. Garcia-Rosa M, et al. Among authors: abraham a. Cytotherapy. 2023 Jun;25(6):578-589. doi: 10.1016/j.jcyt.2023.02.007. Epub 2023 Mar 21. Cytotherapy. 2023. PMID: 36941149 Review.
Cellular therapy for sickle cell disease.
Abraham A, Jacobsohn DA, Bollard CM. Abraham A, et al. Cytotherapy. 2016 Nov;18(11):1360-1369. doi: 10.1016/j.jcyt.2016.06.011. Epub 2016 Jul 14. Cytotherapy. 2016. PMID: 27421743 Free PMC article. Review.
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases.
Arnold SD, Brazauskas R, He N, Li Y, Aplenc R, Jin Z, Hall M, Atsuta Y, Dalal J, Hahn T, Khera N, Bonfim C, Majhail NS, Diaz MA, Freytes CO, Wood WA, Savani BN, Kamble RT, Parsons S, Ahmed I, Sullivan K, Beattie S, Dandoy C, Munker R, Marino S, Bitan M, Abdel-Azim H, Aljurf M, Olsson RF, Joshi S, Buchbinder D, Eckrich MJ, Hashmi S, Lazarus H, Marks DI, Steinberg A, Saad A, Gergis U, Krishnamurti L, Abraham A, Rangarajan HG, Walters M, Lipscomb J, Saber W, Satwani P. Arnold SD, et al. Among authors: abraham a. Haematologica. 2017 Nov;102(11):1823-1832. doi: 10.3324/haematol.2017.169581. Epub 2017 Aug 17. Haematologica. 2017. PMID: 28818869 Free PMC article.
Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell Disease.
Abraham A, Hsieh M, Eapen M, Fitzhugh C, Carreras J, Keesler D, Guilcher G, Kamani N, Walters MC, Boelens JJ, Tisdale J, Shenoy S; National Institutes of Health; Center for International Blood and Marrow Transplant Research. Abraham A, et al. Biol Blood Marrow Transplant. 2017 Dec;23(12):2178-2183. doi: 10.1016/j.bbmt.2017.08.038. Epub 2017 Sep 4. Biol Blood Marrow Transplant. 2017. PMID: 28882446 Free PMC article.
Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine.
Harris AC, Boelens JJ, Ahn KW, Fei M, Abraham A, Artz A, Dvorak C, Frangoul H, Freytes C, Gale RP, Hong S, Lazarus HM, Loren A, Mineishi S, Nishihori T, O'Brien T, Williams K, Pasquini MC, Levine JE. Harris AC, et al. Among authors: abraham a. Blood Adv. 2018 Jun 12;2(11):1198-1206. doi: 10.1182/bloodadvances.2018016956. Blood Adv. 2018. PMID: 29844205 Free PMC article. Clinical Trial.
Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation.
Leonard A, Bertaina A, Bonfim C, Cohen S, Prockop S, Purtill D, Russell A, Boelens JJ, Wynn R, Ruggeri A, Abraham A. Leonard A, et al. Among authors: abraham a. Cytotherapy. 2022 Mar;24(3):249-261. doi: 10.1016/j.jcyt.2021.09.003. Epub 2021 Dec 6. Cytotherapy. 2022. PMID: 34879990
An ISCT Stem Cell Engineering Committee Position Statement on Immune Reconstitution: the importance of predictable and modifiable milestones of immune reconstitution to transplant outcomes.
Bertaina A, Abraham A, Bonfim C, Cohen S, Purtill D, Ruggeri A, Weiss D, Wynn R, Boelens JJ, Prockop S; ISCT Committee on Stem Cell Engineering. Bertaina A, et al. Among authors: abraham a. Cytotherapy. 2022 Apr;24(4):385-392. doi: 10.1016/j.jcyt.2021.09.011. Cytotherapy. 2022. PMID: 35331394 Review.
Viral infection in hematopoietic stem cell transplantation: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatment.
Stanojevic M, Bertaina A, Bonfim C, Ciccocioppo R, Cohen S, Purtill D, Ruggeri A, Russell A, Sharma A, Wynn R, Boelens JJ, Prockop S, Abraham A; ISCT working committee on stem cell engineering. Stanojevic M, et al. Among authors: abraham a. Cytotherapy. 2022 Sep;24(9):884-891. doi: 10.1016/j.jcyt.2022.05.010. Epub 2022 Jun 12. Cytotherapy. 2022. PMID: 35705447
Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering.
Klein OR, Bonfim C, Abraham A, Ruggeri A, Purtill D, Cohen S, Wynn R, Russell A, Sharma A, Ciccocioppo R, Prockop S, Boelens JJ, Bertaina A. Klein OR, et al. Among authors: abraham a. Cytotherapy. 2023 May;25(5):463-471. doi: 10.1016/j.jcyt.2022.12.005. Epub 2023 Jan 27. Cytotherapy. 2023. PMID: 36710227 Free article.
Engineering the best transplant outcome for high-risk acute myeloid leukemia: the donor, the graft and beyond.
Belbachir S, Abraham A, Sharma A, Prockop S, DeZern AE, Bonfim C, Bidgoli A, Li J, Ruggeri A, Bertaina A, Boelens JJ, Purtill D; Stem Cell Engineering Committee of the International Society for Cell and Gene Therapy. Belbachir S, et al. Among authors: abraham a. Cytotherapy. 2023 Dec 4:S1465-3249(23)01103-9. doi: 10.1016/j.jcyt.2023.11.004. Online ahead of print. Cytotherapy. 2023. PMID: 38054912
2,308 results